Latest Asx News

Paradigm Biopharmaceuticals has secured independent validation of its Phase 2 iPPS biomarker study, published in a leading rheumatology journal, reinforcing the scientific basis for its Phase 3 osteoarthritis trial.

Epsilon Healthcare has posted a record $2.891 million in receipts for the December 2025 quarter, nearly doubling year-on-year revenue and marking a significant turnaround with its recent ASX reinstatement.

Audalia Resources is progressing its Medcalf vanadium-titanium-iron project with an updated Pre-feasibility Study and fresh capital injection, positioning the company for its maiden ore reserve announcement.

Mount Ridley Mines has announced a maiden scandium mineral resource estimate of nearly 368 million tonnes at its Mount Ridley Project in Western Australia, positioning it among the world’s largest scandium deposits.

Pilot Energy has successfully raised $3.44 million through a placement to fund its Cliff Head operations and emerging carbon capture projects, signalling a strategic push into clean energy transition.

Globe Metals & Mining has officially started construction at its fully permitted Kanyika Niobium Project in Malawi, marking a key shift from planning to execution with first oxide production targeted for early 2028.

NoviqTech Limited has secured a controlling stake in Coralia, an Australian biochar carbon removal company, positioning itself at the forefront of the rapidly expanding carbon dioxide removal market driven by data centre growth.

Powerhouse Ventures reports its inaugural operating cash flow positive quarter alongside strong fund performance and strategic fund launches, signalling a turning point for the investment house.

Tinybeans Group’s acquisition of US-based Qeepsake fuels a sharp revenue jump and improved profitability in Q2 FY26, signalling early success in its growth strategy.

Siren Gold Limited has advanced its New Zealand gold and antimony projects with a major drilling campaign at Sams Creek and promising exploration results at Queen Charlotte, while navigating regulatory hurdles.

Atomo Diagnostics reported a robust 121% quarter-on-quarter revenue increase to $1.5 million, driven by new orders for its FebriDx Pascal and HIV Self-Test products. The company also secured a global licensing deal for a novel liver function test and expanded manufacturing capacity to support growing demand.

Arika Resources has reported significant extensions to gold mineralisation at its Yundamindra Gold Project in WA, alongside a successful $5.7 million capital raising and strategic asset sale.